Identification of risk factors for post-induction hypotension in patients receiving 5-aminolevulinic acid: a single-center retrospective study.

5-Aminolevulinic acid Anesthesia Hypotension

Journal

JA clinical reports
ISSN: 2363-9024
Titre abrégé: JA Clin Rep
Pays: Germany
ID NLM: 101682121

Informations de publication

Date de publication:
12 May 2020
Historique:
received: 02 03 2020
accepted: 30 04 2020
entrez: 14 5 2020
pubmed: 14 5 2020
medline: 14 5 2020
Statut: epublish

Résumé

5-Aminolevulinic acid (5-ALA) is useful as a photodynamic agent, but its use commonly leads to hypotension. Although avoiding a mean arterial pressure (MAP) < 60 mmHg is important, the incidence of MAP < 60 mmHg when using 5-ALA is unclear. Therefore, we conducted a retrospective study to assess the incidence of post-induction hypotension and identified risk factors of this phenomenon. One-hundred and seventy-two consecutive patients who underwent transurethral resection of the bladder tumor or craniotomy with the use of 5-ALA were enrolled. The primary outcome was the incidence of post-induction hypotension, defined as MAP < 60 mmHg during the first 1 h after anesthesia induction. We divided participants into the normal blood pressure group (group N) and the hypotension group (group L). The incidence of post-induction hypotension was 70% (group L = 121, group N = 51). Multivariate analysis revealed that female sex was an independent factor of post-induction hypotension (odds ratio [OR] 3.95; 95% confidence interval [CI] 1.21-12.97; p = 0.02). Systolic blood pressure < 100 mmHg before anesthesia induction and general anesthesia were also identified as significant independent factors (OR 13.30; 95% CI 1.17-151.0; p = 0.04 and OR 25.84; 95% CI 9.80-68.49; p < 0.001, respectively). The incidence of post-induction hypotension was 70% in patients using 5-ALA. Female sex, systolic blood pressure < 100 mmHg before anesthesia induction, and general anesthesia might be independent factors of post-induction hypotension when using 5-ALA.

Sections du résumé

BACKGROUND BACKGROUND
5-Aminolevulinic acid (5-ALA) is useful as a photodynamic agent, but its use commonly leads to hypotension. Although avoiding a mean arterial pressure (MAP) < 60 mmHg is important, the incidence of MAP < 60 mmHg when using 5-ALA is unclear. Therefore, we conducted a retrospective study to assess the incidence of post-induction hypotension and identified risk factors of this phenomenon.
METHODS METHODS
One-hundred and seventy-two consecutive patients who underwent transurethral resection of the bladder tumor or craniotomy with the use of 5-ALA were enrolled. The primary outcome was the incidence of post-induction hypotension, defined as MAP < 60 mmHg during the first 1 h after anesthesia induction. We divided participants into the normal blood pressure group (group N) and the hypotension group (group L).
RESULTS RESULTS
The incidence of post-induction hypotension was 70% (group L = 121, group N = 51). Multivariate analysis revealed that female sex was an independent factor of post-induction hypotension (odds ratio [OR] 3.95; 95% confidence interval [CI] 1.21-12.97; p = 0.02). Systolic blood pressure < 100 mmHg before anesthesia induction and general anesthesia were also identified as significant independent factors (OR 13.30; 95% CI 1.17-151.0; p = 0.04 and OR 25.84; 95% CI 9.80-68.49; p < 0.001, respectively).
CONCLUSIONS CONCLUSIONS
The incidence of post-induction hypotension was 70% in patients using 5-ALA. Female sex, systolic blood pressure < 100 mmHg before anesthesia induction, and general anesthesia might be independent factors of post-induction hypotension when using 5-ALA.

Identifiants

pubmed: 32399904
doi: 10.1186/s40981-020-00340-9
pii: 10.1186/s40981-020-00340-9
pmc: PMC7218031
doi:

Types de publication

Journal Article

Langues

eng

Pagination

35

Références

JA Clin Rep. 2019 Sep 4;5(1):58
pubmed: 32025993
J Pharmacol Exp Ther. 2016 Feb;356(2):267-75
pubmed: 26588930
Arab J Urol. 2017 Mar 06;15(2):100-109
pubmed: 29071138
Front Oncol. 2019 Jul 17;9:620
pubmed: 31380272
Acta Anaesthesiol Scand. 2003 Mar;47(3):241-59
pubmed: 12648189
Br J Anaesth. 2019 May;122(5):563-574
pubmed: 30916004
Int J Urol. 2019 Nov;26(11):1064-1068
pubmed: 31512303
Photodiagnosis Photodyn Ther. 2013 Dec;10(4):362-7
pubmed: 24284086
Med Mol Morphol. 2018 Dec;51(4):187-193
pubmed: 29619546
Am J Physiol Lung Cell Mol Physiol. 2006 Sep;291(3):L337-44
pubmed: 16899710
Photodiagnosis Photodyn Ther. 2013 Feb;10(1):39-41
pubmed: 23465371
J Urol. 2017 Mar;197(3 Pt 1):548-558
pubmed: 27780784

Auteurs

Tomoaki Yatabe (T)

Department of Anesthesiology and Intensive Care Medicine, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan. yatabe@kochi-u.ac.jp.

Takashi Karashima (T)

Department of Urology, Kochi Medical School, Kochi, Japan.

Motohiko Kume (M)

Medical safety management center, Kochi Medical School Hospital, Kochi, Japan.

Yu Kawanishi (Y)

Department of Neurosurgery, Kochi Medical School, Kochi, Japan.

Hideo Fukuhara (H)

Department of Urology, Kochi Medical School, Kochi, Japan.

Tetsuya Ueba (T)

Department of Neurosurgery, Kochi Medical School, Kochi, Japan.

Keiji Inoue (K)

Department of Urology, Kochi Medical School, Kochi, Japan.

Yoshiyasu Okuhara (Y)

Center of Medical Information Science, Kochi Medical School, Kochi, Japan.

Masataka Yokoyama (M)

Department of Anesthesiology and Intensive Care Medicine, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.

Classifications MeSH